Abstract:Ligands in many instances interact with a protein at multiple sites with a range of affinities. In the present study, ligand-protein interaction sites on Human Serum Albumin (HSA) are mapped using the site-identification by ligand competitive saturation (SILCS)-Biologics approach in conjunction with Hydrogen-Deuterium Exchange (HDX)-Mass Spectrometry (MS) experiments. Ligands studied include known HSA binders, Ibuprofen and Ketoprofen, and compounds Arginine, Alanine, Sucrose and Trehalose, excipients used in therapeutic formulations of protein-based drugs. In addition, the impact of excipient binding to HSA on its stability is investigated through temperature-ramp stability studies monitoring solution viscosity. For the studied ligands, interactions that correspond to known drug-binding sites (DS) are identified. These include previously identified Ibuprofen and Ketoprofen interaction sites as well as additional sites and, in the case of the excipients, the ligands are shown to also bind at previously unidentified lower affinity interaction sites, termed excipients sites (ES) with 20 or more sites identified for the studied compounds. HDX-MS titrations were used to determined dissociation constants for a subset of the interaction sites for Ibuprofen, Ketoprofen, Arginine, and Sucrose, which exhibited Kd values in the low micromolar to millimolar range in satisfactory agreement with SILCS-Biologics predicted affinities, validating the computational approach to identify both high and low affinity interaction sites. The stability studies indicate the excipients to offer protection at low excipient-protein ratios up to 66 with destabilization occurring at ratios above 132 with the exception of Sucrose at the t0 timepoint, indicating that the more favorable affinities of Sucrose seen in the SILCS-Biologics and HDX-MS analyses contribute to protein stabilization. These results indicate that ligands can bind to large numbers of interaction sites on proteins, with those interactions having implications for the development of formulations for therapeutic proteins.

Human Serum Albumin Fibril Formation in the Presence of Ligands with Different Affinity

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Molecular Insights into the Binding Selectivity of a Synthetic Ligand DAAG to Fc Fragment of IgG

Understanding how natural sequence variation in serum albumin proteins affects conformational stability and protein adsorption

Effects of Ligand Binding on the Mechanical Stability of Protein GB1 Studied by Steered Molecular Dynamics Simulation

Structural and thermodynamic characterization of the allosteric transitions in human serum albumin with metadynamics simulations

Mapping the Distribution and Affinities of Ligand Interaction Sites on Human Serum Albumin

Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin

Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface

The effect of chrysin binding on the conformational dynamics and unfolding pathway of human serum albumin

Serum Albumin Prevents Protein Aggregation and Amyloid Formation and Retains Chaperone-like Activity in the Presence of Physiological Ligands

Inhibiting amyloid-like aggregation through bio-conjugation of proteins with polymer surfactant

Thermal unfolding of alpha-lactalbumin at acidic pH: Insights from molecular dynamics simulations

Conformational Changes of Fibrinogen Adsorption onto Hydroxyapatite and Titanium Oxide Nanoparticles

Deciphering the spectroscopic and thermodynamic aspects of binding of biologically important antioxidants with alkali induced state of human serum albumin

Fluorescence study of the interaction between albumin and layered double hydroxides

Structural Basis of the Drug-binding Specificity of Human Serum Albumin

Isothermal titration calorimetry and stopped flow circular dichroism investigations of the interaction between lomefloxacin and human serum albumin in the presence of amino acids

Investigation on conformational variation and fibrillation of human serum albumin affected by molybdenum disulfide quantum dots

Multi Technique Investigation on Binding Interaction between 5-(2-Thiazolylazo)-2,4,6-Triaminopyrimidine and Hsa and Bsa

Study of the fibrinogen structure by the method of small-angle synchrotron scattering